Abiopharma

Became an interested party – Clal Insurance Enterprises Holdings Ltd.

Europe’s Payments Leaders Gather in London as Control, Fraud and AI Reshape the Industry

Holding(s) in Company

Ingredion annonce une offre publique recommandée d’acquisition de Tate & Lyle intégralement en numéraire

Ingredion gibt empfohlene bar finanzierte Übernahme von Tate & Lyle bekannt

Press Release: Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy

Apollo Adds Senior Policy and Government Affairs Leaders in Europe

TGS Begins First Phase of Major Offshore Seismic Dataset in Equatorial Guinea

Communiqué de presse : Sanofi fait le point sur l’étude de phase 3 MOBILIZE, qui évalue le riliprubart dans la polyneuropathie inflammatoire démyélinisante chronique

Applied Materials Expands Singapore Manufacturing to Support AI Chip Demand

Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering

Equity Listing - Ordinary Shares: Allotment and Issue of 2,500,000 New Shares Pursuant to Exercise of Warrants

General Announcement: Net Asset Value ("NAV") as of 09 June 2026

Asset Acquisitions and Disposals: RECEIPT OF WHITEWASH WAIVER FROM THE SECURITIES INDUSTRY COUNCIL

Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering